O
ISSUER//CIK 0001850838
Omega Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K154.4 KBOmega Therapeutics, Inc.Dec 31, 5:30 PM ET·0001193125-24-287201
- 8-K148.5 KBOmega Therapeutics, Inc.Dec 6, 5:00 PM ET·0001193125-24-272532
- 8-K7.9 MBOmega Therapeutics, Inc.Nov 14, 4:16 PM ET·0001193125-24-258595
- 10-Q9.9 MBOmega Therapeutics, Inc.Nov 14, 4:00 PM ET·0000950170-24-127008
- 8-K168.9 KBOmega Therapeutics, Inc.Oct 4, 5:00 PM ET·0000950170-24-112962
- 8-K2.2 MBOmega Therapeutics, Inc.Aug 30, 4:01 PM ET·0000950170-24-102313
- 10-Q12.3 MBOmega Therapeutics, Inc.Aug 6, 7:03 AM ET·0000950170-24-091197
- 8-K348.5 KBOmega Therapeutics, Inc.Aug 6, 7:02 AM ET·0000950170-24-091196
- 8-K294.3 KBOmega Therapeutics, Inc.Jun 24, 4:00 PM ET·0000950170-24-076685
- 8-K/A170.4 KBOmega Therapeutics, Inc.May 30, 5:10 PM ET·0000950170-24-066758
Insiders
10Tickers
No tickers on record
Addresses
business
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141
mailing
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141